Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Speiser

Showing results (761-770 of 1,137) with videos related to

Pageof 114
Sort By:
Cancer Immunology, Immunotherapy : CII|December 21, 2013
Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumabChristiane Meyer, Laurène Cagnon, Carla M Costa-Nunes, et al.
Genome Biology and Evolution|February 8, 2017
The Last Common Ancestor of Most Bilaterian Animals Possessed at Least Nine OpsinsM Desmond Ramirez, Autum N Pairett, M Sabrina Pankey, et al.
Journal of the American College of Cardiology|September 10, 2021
High-Sensitivity C-Reactive Protein Modifies the Cardiovascular Risk of Lipoprotein(a): Multi-Ethnic Study of AtherosclerosisWei Zhang, Jaime Lynn Speiser, Fan Ye, et al.
Cancer Cell|July 14, 2021
The role of exhaustion in CAR T cell therapyGreg M Delgoffe, Chenqi Xu, Crystal L Mackall, et al.
The New England Journal of Medicine|August 19, 2000
High plasma levels of factor VIII and the risk of recurrent venous thromboembolismP A Kyrle, E Minar, M Hirschl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Messenger RNA determination of estrogen receptor, progesterone receptor, pS2, and plasminogen activator inhibitor-1 by competitive reverse transcription-polymerase chain reaction in human breast cancerD Tong, C Schneeberger, K Czerwenka, et al.
Plos One|April 1, 2014
Development of a T cell receptor targeting an HLA-A*0201 restricted epitope from the cancer-testis antigen SSX2 for adoptive immunotherapy of cancerDaniel Abate-Daga, Daniel E Speiser, Nachimuthu Chinnasamy, et al.
Molecular Immunology|July 10, 2020
Identification of a superagonist variant of the immunodominant Yellow fever virus epitope NS4b <sub>214-222</sub> by combinatorial peptide library screeningAmandine Bovay, Vincent Zoete, Pierre J Rizkallah, et al.
Oncoimmunology|August 28, 2020
LAG-3 and PD-1+LAG-3 inhibition promote anti-tumor immune responses in human autologous melanoma/T cell co-culturesNicolas Gestermann, Damien Saugy, Christophe Martignier, et al.
Journal of Cancer Research and Clinical Oncology|January 27, 2026
Not all information is equally important: informed consent to genetic testing for hereditary cancerPaula Thomas, Sven Asmussen, Katharina Klein, et al.
Pageof 114

Showing results (761-770 of 1,137) with videos related to

Sort By:
Pageof 114
Cancer Immunology, Immunotherapy : CII|December 21, 2013
Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumabChristiane Meyer, Laurène Cagnon, Carla M Costa-Nunes, et al.
Genome Biology and Evolution|February 8, 2017
The Last Common Ancestor of Most Bilaterian Animals Possessed at Least Nine OpsinsM Desmond Ramirez, Autum N Pairett, M Sabrina Pankey, et al.
Journal of the American College of Cardiology|September 10, 2021
High-Sensitivity C-Reactive Protein Modifies the Cardiovascular Risk of Lipoprotein(a): Multi-Ethnic Study of AtherosclerosisWei Zhang, Jaime Lynn Speiser, Fan Ye, et al.
Cancer Cell|July 14, 2021
The role of exhaustion in CAR T cell therapyGreg M Delgoffe, Chenqi Xu, Crystal L Mackall, et al.
The New England Journal of Medicine|August 19, 2000
High plasma levels of factor VIII and the risk of recurrent venous thromboembolismP A Kyrle, E Minar, M Hirschl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Messenger RNA determination of estrogen receptor, progesterone receptor, pS2, and plasminogen activator inhibitor-1 by competitive reverse transcription-polymerase chain reaction in human breast cancerD Tong, C Schneeberger, K Czerwenka, et al.
Plos One|April 1, 2014
Development of a T cell receptor targeting an HLA-A*0201 restricted epitope from the cancer-testis antigen SSX2 for adoptive immunotherapy of cancerDaniel Abate-Daga, Daniel E Speiser, Nachimuthu Chinnasamy, et al.
Molecular Immunology|July 10, 2020
Identification of a superagonist variant of the immunodominant Yellow fever virus epitope NS4b <sub>214-222</sub> by combinatorial peptide library screeningAmandine Bovay, Vincent Zoete, Pierre J Rizkallah, et al.
Oncoimmunology|August 28, 2020
LAG-3 and PD-1+LAG-3 inhibition promote anti-tumor immune responses in human autologous melanoma/T cell co-culturesNicolas Gestermann, Damien Saugy, Christophe Martignier, et al.
Journal of Cancer Research and Clinical Oncology|January 27, 2026
Not all information is equally important: informed consent to genetic testing for hereditary cancerPaula Thomas, Sven Asmussen, Katharina Klein, et al.
Pageof 114